Current members of TAG
| Member | Role | Centre |
| Rushil Patel | Physicist and Chair | RTTQA, Mount Vernon Cancer Centre |
| John Lilley | Physicist | Leeds Teaching Hospitals NHS Trust |
| Jenny Marsden | Physicist | Hull and East Yorkshire Hospitals NHS Trust |
| Paul Laycock | Physicist | GenesisCare |
| Patty Díez | Physicist | RTTQA, Mount Vernon Cancer Centre |
| Helen Grimes | Physicist | University College London Hospitals NHS Foundation Trust |
| Helen Howard | Physicist | University Hospital Birmingham NHS Foundation Trust |
| Matt Beasley | Radiographer | Leeds Teaching Hospitals NHS Trust |
| James Barber | Radiographer | Royal Free Hampstead NHS Trust |
| Joanna Henderson | Radiographer | Edinburgh Cancer Centre |
| Ceri Powell | Clinical Oncologist | Velindre NHS Trust |
| Emma Dunne | Clinical Oncologist | BC Cancer Centre, Vancouver |
Current Commitments
SABR TAG are currently updating the technical chapters of the SABR Consortium Guidelines to be released in 2023.
Previous Work
The TAG organised and delivered a workshop to share knowledge regarding motion management of patients with a focus on patients with abdominal tumours. The results from a 2018 National SABR Survey were published in BJROpen in 2019 (Distefano G, Garikipati S, Grimes H, Hatton M. Current status of stereotactic ablative body radiotherapy in the UK: six years of progress. BJR Open. 2019 Jul 19;1(1):20190022. doi: 10.1259/bjro.20190022. PMID: 33178949; PMCID: PMC7592489).
The group has supported the implementation of the NHS England Commissioning through Evaluation (CtE) programme which has allowed a number of centres to treat oligometastatic disease, HCC and re-irradiation with SABR. As part of this commissioning programme the group also supported the development of the national SABR spine audit. The experience gained through this programme was used by the group to update the Consortium guidelines, with version 6.1 released in 2019.
The QA group has previously carried out an in depth Survey of SABR in the UK. The results are reported in: Survey of stereotactic ablative body radiotherapy in the UK by the QA group on behalf of the UK SABR Consortium. Br J Radiol. 2014 May; 87(1037):20130681. doi: 10.1259/bjr.20130681.
During 2013/2014, funding was secured for a Mentoring Program which supported 3 centres in implementing Lung SABR.
A lung SABR dosimetry audit was also carried out. Abstracts summarising results were presented at ESTRO 2015 (OC-0155: UK SABR Consortium Lung Dosimetry Audit; absolute dosimetry results. Radiotherapy and Oncology.2015;115: S75 – S76. OC-0154: UK SABR Consortium Lung Dosimetry Audit; relative dosimetry results. Radiotherapy and Oncology, Volume 115 , S74 – S75). A full length paper has also been submitted to Radiotherapy and Oncology.